← Browse by Condition
Medical Condition
diffuse large b cell lymphoma dlbcl
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 3, Phase 2
NCT07084662 Phase 2, Phase 3
Recruiting
Xinlikang Capsule for Chemotherapy-induced Fatigue and Immune Disorders in Diffuse Large B Lymphoma
Enrollment
80 pts
Location
China
Sponsor
Sun Yat-sen University
NCT07189065 Phase 2
Recruiting
A Study of Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma
Enrollment
150 pts
Location
China
Sponsor
Guangzhou Lupeng Pharmaceutica...